Every cell in the body normally has its fixed place as part of a tissue structure. Except for a few cell types, such as blood ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

The company's blockbuster drug Keytruda contributed $29.48 billion in sales in 2024, but the first of its patent expirations begins in 2028.

A coroner found there were "missed opportunities" to treat a 38-year-old woman with cancer. Carla Smith, 38, who died on 7 ...

"The lack of a significant link between AmygA and LN metastasis in premenopausal women suggests that menopausal status may ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free survival, but ...

Steph was diagnosed with incurable endometrial cancer in 2023 and found microvolunteering the perfect way to give back to ...

Approximately 25% of women develop recurrence or distant metastasis. Laparoscopic surgery for stage I endometrial cancer produces better short-term outcomes and fewer severe postoperative ...

The American Cancer Society's annual cancer trend report shows cancer mortality is decreasing but cancer rates are increasing in young adults and women.

Getty Deaths from uterine cancer are also on the rise, as the study says it’s “one of the few cancers with increasing mortality; from 2013 to 2022 the death rate rose by 1.5% per year.” ...